P

Pfizer

Makes cancer drugs, vaccines and other medicines

Key Account Manager

Full-TimePosted on 10/16/2026Deadline 10/31/26
$176.6k - $294.3k/yr+ 20% target bonus + Share-based long-term incentive
Senior, Expert
Bachelor's, Master's, MBA
Michigan, USA
Remote
Sales & Account ManagementAccount Management
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree is required.
  • Five to ten years of pharmaceutical, biotech, medical, marketing, or sales experience is preferred, including at least three years in a promoted position and/or developmental role with demonstrated leadership across peer and manager groups.
  • Management and/or account management experience is strongly preferred.
  • Demonstrated knowledge of the healthcare market and disease states, ability to develop and manage relationships with key accounts and decision makers, account management and negotiation skills, and ability to prioritize resources and develop business plans.
  • Financial acumen.
  • Market and business strategy knowledge.
  • Account and customer management knowledge.
  • Functional knowledge.
  • Ability to understand, influence, and adapt to changing local healthcare, key customer, and stakeholder needs; assess and prioritize accounts and resources; align account needs with company goals; understand healthcare and market trends; and develop account plans.
  • Data analytics and interpretation.
  • Strategic planning.
  • Critical and analytical thinking.
  • Execution and measurement of outcomes.
  • Ability to build and maintain trusting relationships; persuasive oral and written communication; effective listening and audience-aware communication; and understanding of the role within the broader company and healthcare environment.
  • Value proposition management.
  • Networking.
  • Stakeholder management.
  • Influencing without authority.
  • Ability to uphold company values, provide a vision for delivering goals, adapt to challenges and ambiguity, stay focused on performance, and coach others through change.
  • Self-awareness.
  • Commitment to compliance.
  • Straight talk.
Responsibilities
  • Identify key customers and the internal and external decision-making and influencing networks affecting key accounts and local health economies.
  • Maintain effective relationships with key customer executives, administrative leaders, and decision makers within key accounts.
  • Develop effective relationships with key opinion leaders and stakeholders in local health economies.
  • Understand and seek to influence local, regional, and national healthcare issues and best practices aligned with the market and key accounts.
  • Manage the co-development and co-execution of project plans, holding the customer and the company accountable for execution.
  • Manage prioritized accounts to achieve agreed business objectives.
  • Identify opportunities for synergy and collaboration through active, transparent customer and account planning to achieve company and customer goals.
  • Analyze the local environment, key account business models, and company priorities to create account plans identifying mutually beneficial opportunities.
  • Use the company's value proposition to create mutually beneficial business opportunities that lead to action.
  • Connect and communicate insights from multiple stakeholders to develop action plans beneficial to patients, customers, and the company.
  • Lead and support the development of high-functioning integrated account teams, collaborating with cross-functional specialists and stakeholders to align and leverage roles, responsibilities, and resources compliantly.
  • Partner with integrated account teams to facilitate colleague understanding of local market and customer drivers.
  • Influence local, regional, or national key account management efforts by partnering with cross-functional teams to shape compliant efforts and deliver results.
  • Share and scale proven practices across the region and nation.
  • Serve as a local expert on healthcare reform, the evolving landscape, and account and customer organization.
  • Lead development of strategic planning priorities for aligned key accounts.
  • Apply market knowledge and healthcare dynamics to understand account behavior and involve colleagues from other functions to build and execute strategic plans addressing issues and problems.
  • Use organizational awareness and align company priorities to involve appropriate colleagues and optimize value for customers and the company.
  • Lead pull-through activities aligned with business leader direction.
  • Communicate short-, medium-, and long-term company business opportunities with key accounts, aligning the company portfolio across business units when appropriate.
  • Provide regional marketing and strategy teams with customer-specific insights to inform strategic direction and market-specific materials.
Desired Qualifications
  • An MBA or advanced degree in a related field.
  • Five to ten years of previous pharmaceutical, biotech, medical, marketing, or sales experience, including at least three years in a promoted position and/or developmental role with demonstrated leadership across peer and manager groups.
  • Management and/or account management experience.
  • Leadership experience and capabilities, including influencing and collaborating with peers, developing and coaching others, and overseeing and guiding colleagues' work to achieve outcomes and business impact.

About the company

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-3%

2 year growth

-3%
Yahoo Finance
Oct 19th, 2026
Five low-beta dividend stocks: Pfizer yields 5.83%, Coca-Cola raises payout since 1999

Five defensive dividend stocks offer income with less volatility than the broader market, according to a 24/7 Wall St. analysis. All five have a beta well below 1, meaning they have historically moved less than the market. Pfizer leads with a forward yield of 5.83% at $29.49 a share. AT&T yields 4.77% at $23.27, and its $1.11 dividend uses about 42% of 2026 free cash flow guidance of $18B+. Debt of $144B is its main risk. Dominion Energy yields 4.24%, while Coca-Cola and Colgate-Palmolive each yield 2.27%. Coca-Cola has raised its dividend every year since 1999, and Colgate's next ex-dividend date is October 20, 2026.

Yahoo Finance
Oct 15th, 2026
GSK beats Pfizer as dividend stock: 39% payout vs 89% of free cash flow

GSK looks the better dividend stock than Pfizer, according to a comparison of the two drugmakers, which both face major patent losses before 2030. Pfizer yields 6.3% and GSK 4.1%. Over the twelve months to June 2026, Pfizer paid out 89% of its free cash flow in dividends ($9.79 billion of $10.98 billion), against 39% at GSK (£2.67 billion of £6.90 billion). Pfizer's chief executive officer, Albert Bourla, said the dividend will be maintained even in "the most stretched scenarios." Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion. GSK raised its dividend 17.6% in fiscal 2025 after an earlier cut, and Q2 2026 sales rose 5%. Its main risk is debt: net debt rose to £22 billion after the Nuvalent acquisition.

Yahoo Finance
Oct 14th, 2026
Pfizer's 6% dividend pays investors to wait as oncology pipeline drives growth beyond COVID-19

Pfizer offers a dividend yield of just over 6% while it builds growth beyond its COVID-19 products. The drugmaker declared a quarterly dividend of $0.43 in June 2026, its 351st consecutive quarterly payment. In the second quarter, revenue from launched and acquired products rose 18% year over year. Pfizer raised the midpoint of its full-year guidance, helped by stronger non-COVID sales from drugs such as Eliquis, Padcev, and Vyndaqel. Oncology is the next focus. Pfizer is investing in antibody-drug conjugates and bispecific antibodies, and it entered a global collaboration with Innovent Biologics covering 12 early-stage cancer programs. Not every experimental drug will succeed, but a broader pipeline improves the odds. If new medicines work, the share price could rise on top of the dividend income.

Yahoo Finance
Oct 13th, 2026
Six high-yield dividend stocks fail the payout test, from Ford to Whirlpool's 9.37% mirage

High dividend yields can hide weak payouts, and a four-step test helps separate real income from traps. It checks earnings with one-offs stripped out, full-year free cash flow against dividends, management's explanation, and whether debt funds the gap. Ford yields 4.99% and shows a trailing EPS of -$1.88, caused by $4.2B in one-time charges. Its debt-to-equity of 4.66 leaves the $0.60 dividend exposed to a downturn. Pfizer yields 6.03%, but its free cash flow yield is 5.60%. Clorox's roughly $405M of free cash flow fell short of about $601M in dividends. Whirlpool fails every step. It cut its quarterly dividend from $1.75 to $0.90 in 2025, paid no common dividend in the second quarter of 2026, and its shares are down 59.48% since the end of 2025. 3M and Dow pass, with payouts now covered by cash.

Yahoo Finance
Oct 12th, 2026
UPS, Pfizer, Kraft Heinz and Ford dividends at risk as payouts outstrip earnings

Four blue chip companies, UPS, Pfizer, Kraft Heinz, and Ford, may struggle to sustain their dividends, according to an analysis of their earnings, cash flow, and debt. UPS yields 7.02% and pays out about 121% of its GAAP earnings. Pfizer yields 6.10%, with a GAAP payout ratio of about 226%; its 2025 free cash flow of $9.076 billion fell short of $9.771 billion in dividends. Kraft Heinz yields 6.82%, but its trailing GAAP earnings per share are −$2.88 after $7.4 billion in impairments. Ford yields 4.98% after an $8.162 billion loss in 2025, and its debt-to-equity ratio is 4.66. All four companies say their payouts are safe, and each points to adjusted earnings guidance that covers the dividend.